1975
DOI: 10.1093/jnci/54.6.1385
|View full text |Cite
|
Sign up to set email alerts
|

Hormonally Induced Renal Neoplasia in the Male Syrian Hamster and the Inhibitory Effect of 2-Bromo-α-ergocryptine Methanesulfonate 2

Abstract: One group of male Syrian hamsters received diethylstilbestrol (DES) over a period of 9 months. All developed widespread and severe renal tumors. Another group of male Syrian hamsters was given DES plus 2-bromo-alpha-ergocryptine methanesulfonate (CB154) over the same period. These hamsters either did not develop renal tumors or had renal tumors that were minimal in severity. DES treatment induced hyperplastic and neoplastic changes in the intermediate lobe of the pituitary glands of treated animals, increased … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
1

Year Published

1978
1978
2001
2001

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(4 citation statements)
references
References 0 publications
0
3
1
Order By: Relevance
“…First, the DESinduced proliferation of the Fisher rat mammotroph occurs more rapidly than other pituitary systems. The present data show dramatic effects of CB 154 in a matter of weeks; in contrast, up to 9 months of treatment were required to see effects of CB 154 upon melanotroph proliferation [8]. Sec ond, the proliferative response to DES of the Fisher rat mammotroph is unusually large in comparison with the re sponse of other strains of rat [13,22]: consequently, the dopaminergic attenuation of DES-induced proliferation demonstrated in this communication is more pronounced than the effects of dopaminergic agonists reported previ ously.…”
Section: Discussioncontrasting
confidence: 47%
See 1 more Smart Citation
“…First, the DESinduced proliferation of the Fisher rat mammotroph occurs more rapidly than other pituitary systems. The present data show dramatic effects of CB 154 in a matter of weeks; in contrast, up to 9 months of treatment were required to see effects of CB 154 upon melanotroph proliferation [8]. Sec ond, the proliferative response to DES of the Fisher rat mammotroph is unusually large in comparison with the re sponse of other strains of rat [13,22]: consequently, the dopaminergic attenuation of DES-induced proliferation demonstrated in this communication is more pronounced than the effects of dopaminergic agonists reported previ ously.…”
Section: Discussioncontrasting
confidence: 47%
“…In many vertebrate species, a D-2 dopamine receptor occur ring on the surface of the mammotroph regulates the re lease and synthesis of prolactin [2,6,12]. Acute stimulation of this receptor inhibits prolactin release [2,6]: more pro longed stimulation diminishes the capacity of the mammo troph to synthesize prolactin [14], In view of our recent de monstration that chronic stimulation of the D-2 receptor in the intermediate lobe causes this structure to atrophy and earlier demonstrations suggesting a dopaminergic attenua tion of estrogen-induced proliferation of the pituitary gland, it seemed worthwhile to investigate the effects of 2-bromo-alpha-ergocryptine (CB 154) upon the DES-in duced proliferation of the mammotrophs of the Fisher 344 rat pituitary gland [1,8,9,13]. In this communication, we report that CB 154, a potent D-2 agonist, markedly attenu ated the DES-induced proliferation of the mammotrophs of the male Fisher 344 rat [6].…”
mentioning
confidence: 99%
“…NP and some of its derivatives are excreted by the kidney (Drotman, 1980;Knaak et al, 1966) which may deliver a significant dose to the target site, potentially from both blood and urine. Kidney in humans (Concolino et al, 1993) and experimental animals have estrogen receptors (Hamilton et al, 1975;Li and Li, 1996). An estrogen receptor-mediated effect on tubular epithelial cell proliferation has been proposed as a potential cause of acquired cystic kidney disease (Concolino et al, 1993).…”
Section: Discussionmentioning
confidence: 99%
“…This kind of tumor of the intermediate lobe was graded as benign and classified as melanotroph adenoma . Neoplastic transformation of the intermediate lobe has been previously reported in the Syrian hamster exposed to estrogens (Hamilton et al 1975;Saluja et al 1979) and is accompanied by elevated serum α-MSH concentration (Kurl et al 1990). ER mRNA has been demonstrated by in situ hybridization in the intermediate lobe of rodents (Pelletier et al 1988;Stefaneanu et al 1994) and protracted estrogen treatment can also lead to the development of intermediate lobe tumors in some strains of rats.…”
Section: Discussionmentioning
confidence: 91%